| Literature DB >> 32175059 |
Jafar Mehvari Habibabadi1, Mohamad Zare1, Seyed Navid Naghibi1, Mahdieh Afzali1, Iman Adibi2, Nasim Tabrizi3, Seyed Nader Naghibi4.
Abstract
BACKGROUND: Epilepsy is a chronic neurologic condition and affects people of all ages. Seizure clusters are generally referred to seizures that occur at close intervals with complete recovery between attacks. Various studies have reported a variety of frequencies and risk factors for this condition.Entities:
Keywords: Epilepsy; predictors; risk factors; seizure freedom
Year: 2020 PMID: 32175059 PMCID: PMC7050217 DOI: 10.4103/ijpvm.IJPVM_238_18
Source DB: PubMed Journal: Int J Prev Med ISSN: 2008-7802
Demographic specifications
| Variable ( | Mean or frequency |
|---|---|
| Age (years) | 28.33±10.55 |
| Gender | |
| Male | 477 (52.9) |
| Female | 425 (47.1) |
| Marriage | |
| Single | 220 (52.8) |
| Married | 197 (47.2) |
| Handedness | |
| Right | 695 (90.3) |
| Left | 75 (9.7) |
| Education | |
| Uneducated | 72 (3.4) |
| Elementary | 126 (19.7) |
| Higher elementary | 116 (19.2) |
| High school | 248 (38.9) |
| University | 125 (19.6) |
| Job | |
| Unemployed | 126 (45.8) |
| Employed | 149 (54.2) |
| Labor type | |
| Normal vaginal delivery | 733 (86.1) |
| Cesarean section | 118 (13.8) |
Association of assessed factors with clustering of seizures using multinomial logistic regression analysis
| Variable | Seizure cluster | Significance | OR (95% CI) | |
|---|---|---|---|---|
| Yes | No | |||
| Age, years (mean age±SD) | 28.6±9.75 | 28.37±10.646 | 0.792 | 0.997 (0.977-1.018) |
| Sex | ||||
| Male | 46 (9.7) | 427 (90.3) | 0.554 | 1.138 (0.74-1.744) |
| Female | 47 (11.2) | 374 (88.8) | ||
| Marriage | ||||
| Single | 38 (17.3) | 182 (82.7) | 0.673 | 1.118 (0.665-1.879) |
| Married | 31 (15.7) | 166 (84.3) | ||
| Handedness | ||||
| Right | 86 (12.4) | 609 (87.6) | 0.153 | 1.977 (0.776-5.036) |
| Left | 5 (6.7) | 70 (93.3) | ||
| Education | 0.015* | |||
| Uneducated | 1 (11.08) | 21 (88.92) | 0.188 | 0.250 (0.032-1.96) |
| Elementary | 11 (8.7) | 115 (91.3) | 0.416 | 0.778 (0.425-1.425) |
| Guidance school | 9 (7.8) | 107 (92.2) | 0.054 | 0.442 (0.192-1.014) |
| High school | 32 (12.9) | 216 (87.1) | 0.084 | 0.502 (0.23-1.098) |
| University | 20 (16) | 105 (84) | 0.188 | 0.25 (0.032-1.966) |
| Job | 0.740 | |||
| Employed | 23 (15.4) | 126 (84.6) | 0.399 | 0.470 (0.368-1.489) |
| Unemployed | 15 (11.9) | 111 (88.1) | 0.330 | 0.540 (0.319-0.972) |
| Labor type | ||||
| Normal vaginal delivery | 75 (10.2) | 658 (89.8) | 0.107 | 1.579 (0.906-2.753) |
| Cesarean section | 18 (15.3) | 100 (84.7) | ||
| Seizure-free periods | 0 (0) | 31 (100) | 0.000* | |
| Multiple daily | 34 (23.6) | 110 (76.4) | 0.000* | 1.607E9 (2.159E8-1.196E10) |
| Daily | 20 (15.9) | 106 (84.1) | 0.000* | 9.810E8 (1.292E8-7.450E9) |
| Weekly | 23 (11.9) | 171 (88.1) | 0.000* | 6.993E8 (9.298E7-5.260E9) |
| Monthly | 13 (6.9) | 176 (93.1) | 0.000* | 3.840E8 (4.948E7-2.981E9) |
| Seasonal | 1 (1.04) | 95 (98.95) | 0.000* | 5.473E7 (5.473E7-5.473E7) |
| Yearly | 0 (0.00) | 33 (100) | 0.000* | 6.845E8 (4.893E7-2.107E9) |
| Seizure duration (min) 0.204 | ||||
| <1 | 19 (9) | 93 (91) | 0.041 | 1.767 (1.024-3.047) |
| 1–5 | 60 (14.8) | 345 (85.2) | 0.817 | 0.781 (0.097-6.304) |
| Over 5 | 1 (7.1) | 13 (92.9) | 0.130 | 10540E7 (1.54E7-1.540E7) |
| Age of onset, years (mean±SD) | 8.15±7.83 | 13±11.07 | 0.000* | 0.944 (0.917-0.972) |
| Number of currently used antiepileptic drugs (mean±SD) | 2.81±1.11 | 2.47±1.11 | 0.007* | 1.297 (1.075-1.564) |
*Statistically significance: P value <0.05. OR=Odds ratio, CI=Confidence interval, SD=Standard deviation
Association of assessed factors with clustering of seizures using multinomial logistic regression analysis
| Variable | Seizure cluster | Significance | OR (95% CI) | |
|---|---|---|---|---|
| Yes | No | |||
| Perinatal complications | 16 (21.6) | 76 (9.5) | 0.002* | 2.615 (1.434–4.771) |
| Developmental delay | 14 (19.2) | 77 (9.5) | 0.011* | 2.253 (1.202–4.222) |
| Neonatal icterus | 6 (16.2) | 80 (10.2) | 0.247 | 1.704 (0.691–4.199) |
| Febrile convulsions | 8 (8) | 85 (10.6) | 0.396 | 0.72 (0.338–1.536) |
| Head trauma | 22 (11.6) | 82 (10.2) | 0.583 | 1.153 (0.694–1.915) |
| Coma after head trauma | 4 (17.4) | 82 (10.3) | 0.281 | 1.833 (0.61–5.508) |
| CNS infection | 3 (18.8) | 83 (10.4) | 0.293 | 1.982 (0.554–7.088) |
| Brain tumor | 3 (3) | 12 (1) | 0.870 | |
| Intracranial surgery | 2 (8.7) | 85 (10.6) | 0.77 | 0.804 (0.185–3.484) |
| Other illnesses | 9 (25.7) | 79 (9.9) | 0.005* | 3.14 (1.424–6.924) |
| Smoking | 2 (2.5) | 16 (2) | 0.670 | |
| Alcohol abuse | 0 (0) | 4 (100) | 0.999 | |
| Other substances abuse | 0 (0) | 1 (100) | 1 | |
| Parental consanguinity | 19 (30.6) | 81 (10.1) | 0.000* | 3.933 (2.174–7.117) |
| Family history | 20 (12.7) | 81 (10.1) | 0.33 | 1.3 (0.767–2.204) |
| Systemic diseases | 70 (13.8) | 48 (6) | 0.000* | 2.503 (1.531–4.09) |
| Mentation | 61 (13.1) | 63 (7.8) | 0.011* | 1.785 (1.143–2.787) |
| Motor signs | 66 (13.3) | 55 (6.8) | 0.002* | 2.098 (1.313–3.354) |
| Sensory signs | 71 (14) | 46 (5.7) | 0.000* | 2.686 (1.632–4.42) |
| Cranial nerves signs | 69 (13.9) | 48 (6) | 0.000* | 2.506 (1.543–4.069) |
| Cerebellar signs | 68 (14) | 50 (6.2) | 0.000* | 2.491 (1.543–4.022) |
| Seizure classification | 0.387 | |||
| Focal | 68 (73.11) | 555 (78.27) | 0.463 | 0.469 (0.062–3.544) |
| Generalized | 22 (23.65) | 140 (19.74) | 0.573 | 1.55 (0.338–7.101) |
| PNES | 3 (3.22) | 14 (1.97) | 0.547 | 1.569 (0.362–6.806) |
| Seizure type | 0.000* | |||
| Motor | 77 (91.66) | 541 (89.42) | 0.998 | 1.70E+07 |
| Non motor | 4 (4.76) | 47 (7.76) | 0.998 | 1.19E+08 |
| Absence | 2 (2.38) | 5 (0.82) | 0.998 | 2.17E+08 |
| Unclassified | 1 (1.19) | 12 (1. 98) | 0.998 | 4.04E+08 |
| MRI lesion | ||||
| Normal | 24 (29.26) | 70 (14.40) | 0.025* | 2.7 (1.132–6.442) |
| Abnormal | 58 (70.74) | 416 (85.6) | 0.001* | 2.459 (1.43–4.21) |
| Side of MRI lesion | ||||
| Right | 27 (32.39) | 167 (34.36) | 0.573 | 1.27 (0.54–2.95) |
| Left | 23 (28.04) | 186 (38.27) | 0.951 | 0.974 (0.415–2.28) |
| Bilateral | 8 (9.75) | 63 (10.75) | 0.375 | 0.732 (0.211–1.542) |
| MRI pathology | 0.005* | |||
| Tumor | 6 (10.71) | 48 (9.46) | 0.160 | 0.125 (0.07–2.26) |
| Gliosis atrophy | 16 (28.57) | 99 (19.52) | 0.189 | 0.151 (0.09–2.54) |
| MTS | 10 (17.85) | 134 (26.42) | 0.74 | 0.07 (0.04–1.28) |
| Polymicrogyria | 2 (3.57) | 7 (1.38) | 0.44 | 0.28 (0.012–6.91) |
| White matter abnormality | 0 (0) | 13 (2.56) | 0.99 | 6.5 (9E–9) |
| Porencephaly | 2 (3.57) | 25 (4.93) | 0.11 | 0.8 (0.04–1.81) |
| Cortical scar | 0 (0) | 9 (1.77) | 0.99 | 6.51 (9E–9) |
| Hetrotopia | 3 (5.35) | 18 (3.55) | 0.24 | 0.167 (0.08–3.44) |
| FCD | 8 (14.28) | 19 (3.74) | 0.55 | 0.421 (0.023–7.59) |
| Pachygyria | 1 (1.78) | 3 (0.59) | 0.99 | 6.5 (9E–9) |
| Others | 8 (14.28) | 131 (25.83) | 0.056 | 0.061 (0.003–1.069) |
*Statistically significance: P value <0.05. OR=Odds ratio, CI=Confidence interval, CNS=Central nervous system, PNES=Psychogenic nonepileptic seizures, MRI=Magnetic resonance imaging, MTS=Mesial temporal sclerosis, FCD=Focal Cortical dysplasia
Independent t-test between cluster seizure (normal-abnormal)
| Levene’s test for equality of variances | 95% CI of the difference | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Significance | df | Significance (two-tailed) | Mean difference | SE difference | Lower | Upper | |||
| Cluster seizure normal-abnormal | |||||||||
| Equal variances assumed | 36.49 | 0.00 | −3.37 | 566 | 0.001 | −0.133 | 0.039 | −0.21 | −0.56 |
| Equal variances not assumed | −2.79 | 114.52 | 0.006 | −0.133 | 0.038 | −0.22 | −0.39 | ||
*Statistically significance: P value <0.05. CI=Confidence interval, df=Degree of freedom, SE=Standard error
Multivariate analysis of associated risk factors for clustering of seizures
| Variable | Significance | OR (95% CI) |
|---|---|---|
| Education | ||
| Uneducated | 0.160 | |
| 0.120 | 0.068 (1.821-2.088) | |
| Elementary | 0.071 | 0.028 (1.857-1.968) |
| Higher elementary | 0.045* | 0.030 (1.864-1.980) |
| High school | 0.375 | 0.020 (1.831-1.911) |
| University | 0.223 | 0.028 (1.784-1.896) |
| Age of onset | 0.000* | 0.615 (9.367-11.783) |
| Number of currently used Antiepileptic drugs | 0.000* | 0.061 (2.518-2.759) |
| Seizure free periods | 0.000* | 0.037 (2.164-2.313) |
| Seizures frequency | 0.040* | 0.038 (2.217-2.365) |
| Multiple daily | 0.002* | 0.179 (0.196-0.898) |
| Daily | 0.008* | 0.181 (0.127-0.840) |
| Weekly | 0.029* | 0.179 (0.041-0.744) |
| Monthly | 0.022* | 0.181 (0.061-0.772) |
| Seasonal | 0.034* | 0.192 (0.032-0.786) |
| Yearly | 0.044* | 0.176 (0.042-0.823) |
| Seizure type | 0.615 | 0.113 (2.061-2.505) |
| Perinatal complication | 0.079 | 3.354 (0.871-12.914) |
| Developmental delay | 0.695 | 0.704 (0.122-4.07) |
| Other illness | 0.509 | 2.036 (0.247-16.795) |
| Systemic diseases | 0.001* | 0.018 (1.422-1.492) |
| Parental consanguinity Systemic diseases | 0.739 | 1.242 (0.348-4.43) |
| Mentation | 0.889 | 0.9 (0.205-3.948) |
| Motor signs | 0.454 | 0.213 (0.004-12.216) |
| Sensory signs | 1 | 1.491 |
| Cranial nerves signs | 1 | 3.30E+08 |
| Cerebellar signs | 1 | 0.000 |
| Existence of MRI lesion | 0.007* | 0.016 (1.814-1.878) |
| MRI pathology | 0.042* | 0.032 (1.823-1.950) |
| Tumor | 0.366 | 0.153 (−0.163 to 0.440) |
| Gliosis atrophy | 0.462 | 0.151 (−0.185 to 0.407) |
| MTS | 0.230 | 0.150 (−0.114 to 0.475) |
| Polymicrogyria | 0.876 | 0.178 (−0.322 to 0.377) |
| White matter abnormality | 0.140 | 0.169 (−0.083 to 0.583) |
| Porencephaly | 0.268 | 0.159 (−0.136 to 0.488) |
| Cortical scar | 0.201 | 0.150 (−0.103 to 0.487) |
| Hetrotopia | 0.161 | 0.178 (−0.100 to 0.600) |
| FCD | 0.507 | 0.162 (−0.210 to 0.265) |
| Pachygyria | 0.771 | 0.159 (−0.358 to 0.265) |
| Others | 0.450 | 0.331 (−0.400 to 0.900) |
*Statistically significance: P value <0.05. OR=Odds ratio, CI=Confidence interval, MRI=Magnetic resonance imaging, MTS=Mesial temporal sclerosis, FCD=Focal cortical dysplasia